ATXS Stock Earnings: Astria Therapeutics Misses EPS for Q4 2023
![ATXS stock - ATXS Stock Earnings: Astria Therapeutics Misses EPS for Q4 2023](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600-768x432.png)
Source: iQoncept / Shutterstock
Astria Therapeutics (NASDAQ:ATXS) just reported results for the fourth quarter of 2023.
- Astria Therapeutics reported earnings per share of -86 cents. This was below the analyst estimate for EPS of -78 cents.
- The company did not report any revenue for the quarter.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/atxs-stock-earnings-astria-therapeutics-for-q4-of-2023/.
©2024 InvestorPlace Media, LLC